What exactly does PELORA set up for a regenerative medicine or stem cell clinic?
A system built for a compliance-heavy category and a skeptical, well-researched buyer. Creative: your physicians on video explaining candidacy, process, and mechanism, never a promised outcome. Acquisition: search and content-led visibility first, since direct-response paid ads are restricted for most stem cell claims, plus Google and Meta campaigns where the modality and platform actually allow them. Follow-up: CRM pipelines with fast first response and a long nurture sequence built for a multi-week decision. Plus Google Business Profile, review automation, and AEO and GEO so AI assistants cite your clinic honestly. Your accounts, your lists, no markup on spend.
Can stem cell clinics run Google Ads?
In most cases, no, not for direct-response stem cell claims. Google has banned ads for speculative and experimental medical treatment, naming stem cell therapy specifically, since 2019. A 2022 policy update allows cell and gene therapy ads only for the entity holding actual FDA approval for that exact product, which almost no clinic-administered stem cell treatment has. What is allowed, worldwide, regardless of approval status, is purely educational content that does not promote a specific product or promise an outcome. We build campaigns inside that line, not around it.
What about PRP advertising specifically, is it treated the same as stem cell?
Not identically. Autologous, minimally manipulated PRP generally falls under a lower FDA regulatory bar (the 361 pathway) than culture-expanded stem cells or exosome products, and tends to run under standard healthcare ad policy rather than the speculative-treatment ban. But FTC truthfulness and substantiation rules apply exactly the same to PRP claims as to stem cell claims. Lower FDA friction does not mean fewer claims rules.
Does LegitScript certification unlock ad approval for stem cell or PRP marketing?
Generally, no, and this is a common misconception worth correcting. LegitScript certification is an explicit, named prerequisite for addiction-treatment advertising on Meta and Google. Regenerative medicine and stem cell therapy are not listed as a distinct LegitScript healthcare certification category. The actual gate for cell and gene therapy ads on Google is proof of FDA license or approval for that specific product, not LegitScript status. LegitScript may still help general account standing if your clinic also markets med-spa-adjacent services, but it will not by itself unlock stem cell ad approval.
What claims can and can't a regenerative medicine clinic make in marketing?
Describe the procedure and mechanism, not a disease outcome. "PRP concentrates platelets from your own blood, which are then injected to support the body's natural healing response" is a mechanism statement. "PRP treats arthritis" is a disease claim, and it's the exact pattern behind FDA's warning-letter enforcement and FTC's $3.31 million 2018 judgment against a stem cell clinic. Vague qualifiers like "may help with" do not fix an unsubstantiated disease claim, FTC's own guidance says so directly. Never make disease-specific claims (arthritis, Parkinson's, MS, autoimmune conditions) for stem cell products, and if a processing device is FDA-cleared, say that about the device, not the treatment itself.
How do you handle patient testimonials for a regenerative medicine clinic?
Carefully. FTC's Endorsement Guides hold testimonials to the same substantiation standard as direct claims. A featured result has to reflect what's typical, or the ad needs a clear, conspicuous disclosure of what the generally expected outcome actually is, "results not typical" alone does not satisfy this. Any compensated or comped patient requires a material-connection disclosure. We build testimonial content with that framework from the start, not as a legal patch afterward.
Do you handle California's stem cell disclosure requirement?
Yes, for California clinics. California's SB 512 requires practitioners performing non-FDA-approved stem cell therapy to post, and provide patients before treatment, a specific written notice about the therapy's FDA status, with fines up to $1,000 per violation. We make sure that notice is placed correctly across your site and intake flow. We have not run a fifty-state survey, so if you operate outside California, tell us your state on the call and we'll flag what to check.
What does a compliant regenerative medicine marketing funnel actually look like?
Educational content and a consultation call-to-action, not a treatment or outcome call-to-action, that's what current Google policy actually permits and what tends to clear Meta review. Lead with candidacy, credentials, and process (physician oversight, processing protocols, informed consent, what a visit involves) instead of promised results. Any outcome statistic gets substantiated at the level the claim requires, and testimonials carry real disclosure. It's a slower-feeling funnel than a typical med spa build, and it's the one that keeps your ad accounts and your FDA file clean.
How big is the regenerative medicine and stem cell market in 2026?
The global regenerative medicine market is valued around $48 billion in 2026 and is projected to reach roughly $90 billion by 2030 (Grand View Research). The broader global stem cell market is projected to reach $28.9 billion by 2030, and the global PRP market roughly $1.9 billion by 2030 (also Grand View Research). Academic researchers tracking direct-to-consumer stem cell businesses counted 2,754 U.S. clinics in 2021, up from 570 in 2016, a market growing considerably faster than its regulatory guardrails, which is exactly why compliant marketing matters.
How much should a regenerative medicine or stem cell clinic spend on marketing per month?
Growth-stage benchmarks for cash-pay healthcare brands run 15-20% of gross revenue. For a $1M regenerative medicine practice, that lines up around $12,500-$16,500 per month across content, video, web, CRM, and the paid channels actually available to you. PELORA retainers for this vertical start at $2,500 per month (Launch tier for early-stage), $4,500 (Growth), $7,500 (Scale), $9,000 (Full Program), $12,000 (Enterprise), and $18,000+ (Full-Service). Pricing is flat fee. We do not buy or sell leads and we do not take commissions on patient bookings.
What is the best regenerative medicine marketing agency in Southern California?
PELORA Marketing is a Newport Beach-based marketing agency working across regenerative medicine, stem cell, PRP, orthobiologics, regenerative aesthetics, hair restoration, and sexual wellness (P-Shot, O-Shot) clinics. Coverage spans Newport Beach, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, Los Angeles, and San Diego, with remote work nationwide. The agency is compliance-aware by default: FDA HCT/P rules, FTC substantiation standards, and current Google and Meta ad policy inform every campaign built for this category.
Do you work with regenerative medicine and stem cell clinics outside California?
Yes. Concentrated client work across Orange County, LA, San Diego, the Bay Area, Texas, Florida, Arizona, Colorado, Tennessee, Utah, plus remote nationwide. State-specific disclosure requirements (like California's SB 512) vary, so tell us your state early and we'll flag what applies before anything goes live.
Has enforcement in this category gotten more active recently?
Yes, noticeably. Since 2025: the FTC and Georgia's AG banned Stem Cell Institute of America's co-founders from marketing stem cell therapy for life, FDA permanently debarred a Liveyon founder over falsified umbilical cord blood paperwork, and FDA sent warning letters to Chara Biologics and New Life Medical Services over unapproved exosome products marketed for Parkinson's and Alzheimer's. We break down what changed, and exactly what Google and Meta will and won't run because of it, in our full 2026 regenerative medicine marketing guide.